ST. CHARLES, Mo.--(BUSINESS WIRE)--D2 Consulting, a leading life sciences consulting firm offering both strategic and tactical commercialization services to pharmaceutical, biotechnology and medical device manufacturers, announces the appointment of Cheryl Nagowski as senior director, Federal Markets. Nagowski brings more than 15 years’ experience overseeing federal procurements and provides a deep understanding of how to navigate federal regulatory concerns while achieving business objectives.
Dean Erhardt, CEO, D2, says, “Cheryl brings the vision, expertise and experience that D2 clients require in developing and implementing federal market strategies that achieve favorable coverage and reimbursement. Her in-depth knowledge and understanding of this landscape truly expands the breadth of our advisory services and continues to differentiate D2’s market access services.”
Under Nagowski’s leadership, the D2 team of specialists, which includes former Department of Veterans Affairs (VA) and Department of Defense (DoD) chief pharmacists and former legal counsel for the VA Procurement Policy Group, will collaborate to provide best-in-class federal market solutions and strategies.
Bridging her government and biotech careers, Nagowski most recently provided advisory support to pharmaceutical and medical device companies in preparation for federal market drug launch, pricing and contracting disclosure preparation, Federal Supply Schedule implementation, government program integration under M&A, and VA/DoD strategic plan development and implementation.
Prior to this, she managed national and regional payer contracting for Genentech, with primary responsibility for the federal segment. Her responsibilities included Federal Supply Schedule renewal and management for a large portfolio of products, therapeutic class review preparation, and supplemental contracting analysis and strategy development.
Early in her career, Nagowski negotiated high-visibility acquisitions for the DoD. As government contracting officer, she gained a detailed understanding of how to negotiate with and relate to customers in this unique segment.
Nagowski adds, “I am honored to join a leadership team of highly respected thought leaders who consider the federal market of strategic importance to D2 and the clients they serve.”
About D2 Consulting
D2 Consulting is a leading provider of commercialization services to the healthcare and life sciences industries, D2 works across all stakeholders including manufacturers, payers and channel participants to execute strategic business initiatives that ensure successful launch, distribution and reimbursement to maximize market impact and support an ongoing leadership position in the marketplace. Visit http://d2rx.com/.
